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ABSTRACT 
Introduction: To characterize cardiac complications occurring in acute 
ischemic/thrombotic stroke patients admitted to the medical emergency at a tertiary 
care hospital in Chennai, South India. Many extensive studies have been made in the 
past regarding cardiac complications in hemorrhagic stroke especially SAH. 
Methods: Observational study (prospective cum retrospective) done in acute 
ischemic stroke patients admitted within 24 hours of symptom onset. Patients with 
hemorrhage in CT, age less than 18 and TIA were excluded. Electrocardiogram and 
Echocardiography were performed at admission and at the end of 48 hours.  
Results: Hundred patients were included in this study. In our study group, 39 
patients had an ejection fraction less than 50%, twenty patients had ischemic changes 
in the ECG, eleven patients presented with atrial fibrillation and one developed a 
ventricular tachycardia. Subgroup analysis revealed a higher NIHSS score among 
those with systolic dysfunction with ejection fraction less than 40% (10% versus 
2%; p<0.001), atrial fibrillation on ECG (9% versus 3%; p<0.05), ischemic changes 
on ECG (17% versus 3%; p<0.05) compared with those without these changes. 
Conclusion: A subset of acute ischemic stroke patients may have cardiac 
complications. Systolic dysfunction, atrial fibrillation and ischemic changes on ECG 
may be associated with higher in-hospital mortality rate as indirectly evidenced by 
the significant correlation of cardiac complications with severity of stroke. These 
findings support the importance of the adjunctive role of cardiac monitoring 
strategies in acute ischemic stroke. 
KEY WORDS: Acute ischemic stroke, cardiac complications, systolic dysfunction, 
atrial fibrillation, Electrocardiogram.   
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INTRODUCTION 
Any acute insult to the central nervous system has been 
known to cause a wide array of manifestations in the 
cardiovascular system. This can include asymptomatic ST-T 
changes, fatal or non-fatal arrhythmias, ventricular dysfunction, or 
cardiac dysautonomias.
1-3 
 Increase in the levels of serum catecholamines following a 
stroke
4-6
, has been thought to play a role but the intricate 
mechanisms involved is still an enigma. The intrinsic auto 
regulation of blood flow is impaired in the ischemic penumbra, 
making the cerebral perfusion mainly dependent on cardiac 
function.
7-9
Hence, cardiac dysfunction can lead to detrimental 
effects in acute stroke patients. 
 This phenomenon has been well studied in SAH by earlier 
investigators. But whether similar effects cause significant damage 
in ischemic/thrombotic stroke has been less studied.
10
 Inpatients of 
acute ischemic stroke undergo echocardiograms to look for a 
cardio embolic source, but there are no recommendations 
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pertaining to management of systolic or diastolic dysfunction in 
acute ischemic/thrombotic stroke. 
 Early identification of these cardiac manifestations might 
prove valuable in defining a role in the management strategies like 
cardiac augmentation in acute ischemic/thrombotic stroke patients. 
 It had been always the heart to which attention was paid in 
cases of stroke, either as a source of embolism or cause of 
hypoperfusion. Recent turn is in the emphasis towards the 
mechanisms involving the brain injury as a cause for cardiac 
dysfunctions.
11
The insular cortex had been studied and found to 
cause cardiac sympathetic neural upregulation and ECG     
abnormalities.
12-15
 
 Thus cardiac mortality is increased and can become a major 
cause of death in acute strokes. 
 This study is designed to augment the existing studies on 
cardiac dysfunction in acute ischemic/thrombotic stroke. It has 
been hypothesized that a considerable proportion of moderate to 
severe acute ischemic/thrombotic stroke have systolic and diastolic 
ventricular dysfunction. Alternative manifestations like 
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arrhythmias and ST-T changes were also included. This study 
intends to correlate ventricular dysfunction(systolic and diastolic) 
with severity of acute ischemic/thrombotic stroke based on NIHSS.  
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AIMS AND OBJECTIVES 
i) To assess the prevalence of cardiac complications in acute 
ischemic / thrombotic stroke patients with special reference to 
ventricular dysfunction. 
ii) To correlate the cardiac manifestations with the severity of 
stroke based on NIH stroke scale. 
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REVIEW OF LITERATURE 
CEREBROVASCULAR ACCIDENT: 
Stroke is one the commonest causes of death and an 
important cause of disability worldwide. It is described as a 
syndrome of rapid onset neurological deficit which is usually focal 
but may be transient or permanent, the cause being vascular. It is 
the leading cause of neurologic disabilityin adults. The underlying 
vascular mechanism is ischemic in 85% of the cases. Primary 
hemorrhages [subarachnoid and intraparenchymal] constitute the 
remaining 15%. 
The term transient ischemic attack (TIA) denotes an 
ischemic deficit that resolves rapidly (<24 hours) irrespective of 
the occurrence of a new infarct.  Most TIAs last between 5 and 15 
minutes. Recently all brain infarctions are classified as strokes 
regardless of duration of symptoms. 
HISTORICAL PERSPESTIVE 
Galen (131- 201 AD), based on dissections of animals, was 
the first person to described the structure of brain, its anatomy and 
its blood supply.  
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Thomas Wills, a neuro-anatomist proposed the cerebral blood 
vessel anastomoses at the base of brain (CEREBRAL 
ANASTOME), and named after him – CIRCLE OF WILLIS. He 
also described transient ischemic attacks, existence of occlusion of 
carotid artery, and the embolus as etiology for the stroke.  
 In 1960, Hounsfield from Britain, originated the concept of 
Computed Tomography (CT). In the mid-1980, MRI proved 
superior to CT in picking up the old hemosiderin containing 
hemorrhages, vascular malformation, lesion involving posterior 
cranial fossa, lesion abutting on bony surfaces.  
 At the end of 20
th
 century, advanced imaging with CT, MRI 
spectroscopy helped in the localizations, severity and potential 
reversibility of brain ischemia. These advances will help in the 
better management of the stroke in upcoming future. 
INDIAN EPIDEMIOLOGY: 
1) Incidence of stroke  -  119 to 145 per lakhs of population, 
2) Prevalence of stroke – 84 to 262 per lakhs of population (rural),  
334 to 424 per lakhs of population (urban) 
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3) Cases fatality rates – around 25% (urban population), 37% (rural 
population) are died due to stroke and its complication during 28 
days of stroke. Mortality is highest in Kolkata studies (mortality 
rate – 42%). 
4) IV thrombolysis of stroke – 11% of the stroke 
5) Stroke subtypes – 68% cerebral infarct, 32% cerebral hemorrhage 
6) Stress hyperglycemia  prevalence – 14 – 60% 
7) Stroke contributes for 1.2%  of all death in the country 
PATHOPHYSIOLOGY OF ISCHEMIC STROKE: 
Ischemic stroke mostly results from embolic occlusion of 
large cerebralvessels; the major source of emboli is usually the 
heart or the carotid arteries. Intrinsic small-vessel disease results in 
small, deep ischemic lesions (lacunar strokes). Severe proximal 
stenosis and inadequate collaterals challenged by systemic 
hypotensive episodes result in low-flow strokes. The patient may 
experience only transient symptoms, i.e., a TIA, if blood flow is 
restored prior to significant cell death.  
8 
 
When impairment occurs in the blood flow to the brain, the 
neurons and other brain cells have decreased energy substrates. 
They ultimately die unless blood flow is promptly restored. The 
severity of ischemia determines the pattern of cell death. With mild 
ischemia, as occurring in cardiac arrest with reperfusion, certain 
neuronal populations are selectively vulnerable, resulting in their 
preferential loss. More severe ischemia causes selective neuronal 
necrosis, where all neurons die but glia and endothelial cells are 
preserved. Complete, permanent ischemia causes pannecrosis, 
which affects all cell types, resulting in the chronic cavitary brain 
lesions seen after clinical stroke. 
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DAMAGE SPECTRUM IN CEREBRAL ISCHEMIA
 
The above picture emphasizes that cerebral symptoms start 
to appear when the blood flow gets reduced to less than 50% 
causing neuronal electrical dysfunction. If this state sustains, 
ischemic injury to brain follows. 
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HOMEOSTATIC RESPONSE IN BRAIN AFTER STROKE 
 
A- Vasodilation  
B- Decrease in blood flow after maximal vasodilation, but 
increased extraction of O2 maintains the metabolic needs 
C- Further reduction in flow leading to infarction. 
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Ischemic neuronal injury is an active biochemical process 
which evolves over time. Lack of glucose and oxygen results in 
depletion of the cellular energy stores required to maintain 
membrane potentials and transmembrane ion gradients. 
Potassium leaks out of cells, leading to depolarization-induced 
calcium entry and also enhancing the release of glutamate 
through glial glutamate transporters. Synaptic glutamate causes 
activation of excitatory amino acid receptors, which are coupled 
to calcium and sodium preferring ion channels. As a result 
sodium enters into postsynaptic neuronal cell bodies and 
dendrites, causing depolarization and acute swelling. Acidosis 
contributes to intracellular calcium overload by activating acid-
sensing ion channels. Calcium influx which exceeds the ability 
of the cell to buffer, sequester, or extrude calcium activates 
calcium-dependent enzymes (lipases, proteases, and nucleases). 
These enzymes and their metabolic products, such as reactive 
oxygen and nitrogen radicals and eicosanoids, cause the 
breakdown of cytoskeletal elements and plasma membranes, 
leading to cell death.   
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When ischemia is incomplete, it permits more prolonged cell 
survival, as in the border zone or penumbra surrounding the core of 
an ischemic brain region; other biochemical processes that regulate 
cell death are set into motion. These involve the expression of 
proteins engaged in programmed cell death (PCD), such as 
caspases (cysteine protease pro-enzyme which cleaves aspartate 
residues) andBcl-2 family proteins. These proteins act to cause 
apoptosis, a form of PCD that is distinct from necrosis and is 
marked by relative preservation of cell membrane integrity, 
cleavage of DNA into fragments of defined length (nucleosomes), 
margination of nuclear chromatin, blebbing of the cell membrane 
to form apoptotic bodies, and phagocytosis without inflammation. 
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Non-apoptotic forms of PCD also exist which play a role in 
delayed ischemic cell death. 
STROKE SYNDROMES BASED ON ARTERIAL TERRITORY 
 
 
A- Anterior circulation 
B, C, D, E- Partial anterior circulation 
F- Pure motor/lacunar 
G, H, I, K – Posterior circulation 
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Transient ischemic attack (TIA), is defined as temporary 
neurological deficit caused by cerebrovascular disease, 
characterized by no clinical or imaging trace, with complete 
recovery occurring within 24 hours. Onset of stroke differs in 
ischemic and embolic stroke. The thrombotic stroke evolves over 
hours to days, in a saltatory fashion. In the embolic stroke, the 
onset is sudden, peak at once. The static onset & evolves over 
minutes is a feature in hemorrhagic stroke.  
Stroke can be divided into two main subtypes – ischemic or 
hemorrhagic stroke. Ischemic stroke arises as a result of occlusion 
of blood vessels to the brain which leads to sudden cut off of the 
blood supply leading cerebral infarction.   
 Ischemic stroke is further divided into thrombotic stroke & 
embolic stroke. Based on underlying etiology, ischemic stroke, can 
arises from (1) atherosclerosis of large cerebral blood vessels, (2) 
occlusion of small cerebral vessel within brain parenchyma, (3) 
cerebral embolism. Several other causes of brain parenchyma 
infarction includes arterial dissection, vasculitis, hyper-coagulable 
state, cortical vein thrombosis. 
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The distinction between thrombosis and embolism is often 
difficult or impossible to make on clinical grounds. 
Thrombotic strokes are frequently preceded by TIAs, which 
tend to produce similar symptoms as they affect the same territory 
recurrently. 
Embolic strokes typically produce neurologic deficits which are 
maximal at onset. When TIAs precede embolic strokes, chiefly 
those arising from a cardiac source, symptoms characteristically 
vary between attacks as different vascular territories are affected. 
Various conditions like Migraine, Todd paralysis (seizure), 
Brain tumor, and abscess will be imitating stroke and these 
condition should be considered in differential diagnosis. 
BLOOD SUPPLY TO BRAIN: 
1. Internal carotid artery (Right & Left) 
2. Vertebral artery (Right & Left) 
Circle of Willis: is formed anteriorly by two ACA, which is 
connected by anterior communicating artery anteriorly, posteriorly 
by two PCA, communicating with anterior circulation by the 
posterior communicating artery. 
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COLLATERAL BLOOD SUPPLY IN THE BRAIN: 
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In the normal situation, the anterior two-third of the cerebral 
circulation is supplied by the internal carotid artery and the 
posterior one – third is supplied by the vertebral artery. In the cases 
of blood vessels occlusion, collateral develop distal to the site of 
occlusion, and the collateral development depends on the vessels 
occluded, and whether the other artery are free of disease or not.      
 Other regions of collateral blood flow are: 
1. Leptomeningeal anastomoses 
2. Around the orbit  
3. Parenchymal anastomes 
Venous drainage of the brain: 
1.  Superficial cerebral veins 
2.  Deep cerebral veins 
Both these veins drains into the dural venous sinuses, which 
further drains into the internal jugular vein. The cerebral veins 
lacks valves, they are thin walled, & the blood flow in these veins 
are in the same direction as that of the neighboring arteries 
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RISK FACTORS 
Risk factors can be fixed or it can be modified through preventive 
measures. Based on that there are two groups of risk factors. 
1. NON -MODIFIABLE: 
a) Age: the most important risk factor of the stroke, &the risk 
doubles after 55 years, for every decade. 
b) Sex: incidence and mortality of the stroke is higher in male 
gender compared to that of female gender. 
    c) Genetic factors: chromosome 12 polymorphism 
d) Race/Ethnicity: Afro-Caribbeans >Asians >Europeans have 
stroke  incidence in the decreasing order 
2. MODIFIABLE: 
a) Diabetes mellitus: 1.8 to 3.5 times increases in the stroke 
incidence, with most of them are lacunar strokes. 
Hyperglycemia and insulin resistance are the other risk 
factors. 
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b) Systemic hypertension: the most important risk factor in the 
development of ischemic stroke. The incidence is three times 
higher when compared to normotensive people. Recent 
studies revealed that 46% reduction in the stroke incidence 
for every 7.5 mmHg reduction in diastolic BP. Around 40% 
of strokes have a blood pressure of greater than 140mmHg.  
c) Dyslipidemia (elevated LDL cholesterol, elevated 
triglycerides): Statin therapy reduce the stroke incidence by 
20 -30%, because of its action of  stabilizing the plaque, anti-
thrombotic action, improved endothelial function and by 
reducing the inflammation. 
d) Cigarette smoking: increases the risk of all types of stroke. 
The risk is highest in the younger group, with risk 
proportionate to the number of  cigarettes smoked.  
e) Alcohol intake: the risk is variable. Risk is reduced with low 
to moderate consumption. Higher level of consumption 
increases the incidence of   hemorrhagic stroke. 
f) Obesity: along with smoking, a BMI of > 25 kg/m2, account 
for 60% of stroke, in the group of men up to sixty five years 
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g) Transient ischemic attack (TIA): 10 times higher risk of 
stroke when compared to person without stroke. 
h) History of Stroke in the past. 
i) Asymptomatic carotid bruit/stenosis 
j) Cardiac illness: the presence of left ventricular hypertrophy 
by ecg increases ischemic stroke risk by 10 fold, 
presentation of congestive heart failure increases stroke 
incidence by nine fold. Atrial fibrillation raises the risk of 
embolic stroke by 5 to 7 times than age matched population 
of normal cardiac rhythm. Other risk factors include mitral 
valve prolapsed, prosthetic valves, endocarditis, and 
congenital heart diseases. 
k) Aortic arch atheromatous diseases 
l) Increased fibrinogen level 
m) Raised homocysteine level 
n) Decreased serum folate 
o) Increased anti-cardiolipin antibodies 
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p) Oral contraceptive use: risk is higher in young women who 
is taking estrogen content of more than 50 mcg. OCP 
increases ischemic stroke secondary to enhance platelet 
aggregability & alteration in clotting factors. 
q) Anticoagulation therapy: increases risk of hemorrhagic 
stroke. 
r) Intake of low potassium, reduced serum potassium level. 
CLINICAL FEATURES: 
General physical examination may reveal obesity, feeble or 
absent peripheral arterial pulsations, vascular bruits, unequal or 
raised blood pressure, postural hypotension and retinopathy. 
Prodromal warning symptoms of TIA may precede in about 
60% of the patients. Such episodes of TIA are often brief(lasting 
for a few minutes to less than an hour) and may come singly or in 
successive spells over a number of hours or days or months, and 
leave no significant residual signs.  
TIAs may not be always related to posture or the level of BP, 
and may disappear altogether. However, in some cases (10% to 
22 
 
15%),an evolving or a full-blown stroke may follow the last 
ischemic spell. 
When the stroke evolves in a stepwise manner, (‘thrombosis 
in evolution’) the symptoms may appear in each limb in succession 
or simultaneously. This stuttering or intermittent progression is 
typical of atherothrombosis. Not infrequently, the stroke may 
announce itself abruptly as a single major catastrophic 
event(accomplished infarction or completed stroke). The other 
clinical manifestations are based on where the artery is blocked. 
The focal signs and symptoms accompanying ICH reflect the 
location of the hemorrhage and are indistinguishable from ischemia 
occurring in the same vascular territory. Lobar hemorrhages 
frequently produce contralateral weakness or sensory loss, 
language disturbance, hemianopia or lesser field disorders, and 
parietal lobe signs. Their relationship to the cortex makes them 
more likely to be complicated by seizures. Seizure are more 
frequent in ICH, occurring in as many as a quarter of individuals, 
although they are also seen in about 5% of patients with ischemia, 
particularly early after onset. 
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Occasionally, very small hematomas present with symptoms 
indistinguishable from transient ischemic attacks (TIAs).However, 
majority of ICHs cause complete stroke. 
Putaminal hemorrhages typically cause contralateral 
hemiparesis with variable degrees of sensory loss, ataxia and with 
larger hematomas, a homonymous hemianopia. 
Thalamic hemorrhages can result in contralateral sensory 
loss and weakness, while if they extend to or compress the superior 
midbrain, they may result in depressed signs. Pontine hemorrhages 
often result in reduced consciousness, pinpoint pupils, bilateral 
weakness and pontine cranial nerve dysfunction, and may be 
severely disabling. 
Cerebellar hemorrhages are particularly important to identify 
clinically as they may require surgical intervention, which can be 
life-saving. The onset can be deceptive, with initial nonspecific 
brainstem symptoms (e.g. vertigo or double vision),followed a few 
hours or even days later by progressive clinical features, including 
gait, trunk or limb ataxia, nystagmus, headache, vomiting and 
coma from brainstem compression. Hemiparesis will be rare. 
Posterior circulation stroke has an unpredictable clinical course at 
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the time of onset. An abrupt deterioration may occur after an initial 
stable course. Moderate degrees of quadrigeminal cisternal 
compression predicts poor outcome unless the hematoma is 
evacuated early in the course. Severe mass effect on the cistern 
carries a poor prognosis. 
WATER SHED INFARCTS: 
            It occurs in the border region between two arterial territory. 
These infarct are common during or after the surgery, severe 
arterial hypotension after cardiac arrest, prolonged hypoxemia, and 
bilateral severe carotid artery diseases. 
           Ischemia in the border zone of the ACA, MCA & PCA 
manifest in the form of bilateral parieto-occipital infarcts with 
clinical features of visual disturbances, optic ataxia, cortical 
blindness and difficulty in predicting the size, distance and 
movement.  
            Unilateral severe arterial occlusion or stenosis will leads to 
unilateral watershed infarct when these is some degree of 
hemodynamic failure in these patients. This can also occur in the 
situation of microembolism or the hyperviscosity states. 
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             Ischemia between ACA & MCA region results in bilateral 
upper limb cortical sensorimotor impairment (man-in-barrel), 
impaired saccadic eye movements due to involvement of frontal 
eye fields. 
             MCA & PCA territory involvement results in bilateral 
parieto temporal infarction with cortical blindness, defect in the 
verbal & the nonverbal material dyslexia, dyscalculia, dysgraphia. 
                Watershed infarct can also occur in the regions of PICA, 
AICA & SCA., and also involving internal watershed region in the 
centrum semi ovale near to & slightly above the body of lateral 
ventricles.  
INVESTIGATIONS: 
Routine studies include CXR and ECG, blood tests, and imaging. 
Further studies of coagulation are indicated if a hypercoagulable 
state is suspected. 
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IMAGING IN STROKE 
1. Non Contrast CT: 
This is the diagnostic brain imaging study in the initial 
stroke evaluation. 
(A) Hyperacute infarct (<12 hours): in this stage, there will be 
early changes in the form of grey-white matter differentiation will 
be lost, sulcus & Sylvian fissure effacement &obscuration of the 
lentiform nucleus. Dense MCA sign- Horizontal part of the middle 
cerebral artery may appear hyper dense, even before the 
appearance of infarct. 
(B) Subacute infarct (24-48 hours): 
  Wedge shaped area of decreased attenuation involving both the 
grey and with matter in a typical vascular territory. The initial mass 
effect then begin to decrease in 7-10 days. 
(C) Chronic infarct: 
Well delineated, focal areas of encephalomalacia appears in CT 
scans.      
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 Adjacent sulci become prominent and the ventricles on the 
ipsilateral side enlarges. Enhancement disappears after eight to ten 
weeks. 
Scan negative infarct: early scans may be negative in 60% of 
cases within   12 hours of ictus, after 2 -3
rd
 week after infarct 
(blooming). 
2. Multimodal Ct: 
i) Whole brain perfusion CT- identify the cerebral blood volume 
and areas of hypottentuation representing the ischemic core. 
ii) Dynamic perfusion CT – provides absolute measures of cerebral 
blood flow, mean transit time and cerebral blood volume.  
iii) Helical angiography – noninvasive method to assess the 
vasculature of both the intra-cranially and extra- cranially and 
identify the stenosis or occlusion of the vessels.  
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3. Magnetic Resonance Imaging (MRI): 
i) Superior in detecting ischemia, when compared with CT. 
ii) In acute infarct, DWI is highly sensitive in the first few hours 
after infarction. The diffusion restriction in acute infarct will 
appears as high intensity in DWI images with low ADC signal 
and appears dark, and during the initial stages T2 weighted 
images are normal. 
4. Multimodal MRI:  
i) Diffusion weighted MRI (DWI) – identify ischemic regions 
within minutes of symptom onset and early identification of 
lesion size, site & age. 
ii) Perfusion weighted MRI (PWI) – provides relative measures of 
cerebral hemodynamics. The ischemic penumbra is 
approximated on MRI as region of perfusion change without a 
corresponding diffusion abnormality (diffusion perfusion 
mismatch) 
5. MRI angiography: 
Delineates blood flow & vascular lesions, including atheromatus 
plaques in the carotid and vertebrabasiliar systems. Identify the 
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larger blood vessel abnormality better than that of the distal 
lesions. 
6. Other brain imaging: 
Includes oxygen-15 Positron emission tomography (PET); 
Xenon enhanced CT brain; Single photon emission computed 
tomography (SPECT) identifies thresholds of reversible 
ischemia; transcranial Doppler sonography for evaluation of the 
blood flow velocity and patency of the main intracranial arteries. 
7. Duplex Doppler ultrasonography: 
Detection of the carotid artery atheromatous plaques and 
obstruction of the carotid artery. 
8. Echocardiography to assess the potential causes of TIA or evolving 
stroke. 
BLOOD TESTS IN PATIENTS WITH ISCHEMIC STROKE / TIA: 
i) Hemoglobin 
ii) Hematocrit 
iii) WBC count (and differential if abnormally high or low) 
iv) Total platelets 
v) aPTT 
vi) PT-INR 
vii) Serum fibrinogen level 
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viii) Blood sugar 
ix) Serum calcium 
x) Total cholesterol, HDL, LDL. 
xi) Blood urea nitrogen 
xii) Electrolytes (sodium, chloride, potassium, and carbon 
dioxide) 
xiii) Homocysteine 
xiv) C-reactive protein 
xv) Erythrocyte sedimentation rate (ESR) 
TREATMENT: 
ACUTE ISCHEMIC STROKE 
Treatments designed to reverse or lessen tissue infarction in acute 
ischemic stroke include:  
(1) Medical support,  
(2) Thrombolysis and endovascular techniques,  
(3) Antiplatelet agents,  
(4) Anticoagulation and  
(5) Neuroprotection. 
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MEDICAL SUPPORT: 
It optimizes perfusion in ischemic penumbra surrounding the 
infarct. 
 Blood pressure should never be lowered precipitously 
(exacerbates the underlying ischemia), and only in the most 
extreme situations should gradual lowering be undertaken (e.g., 
malignant hypertension with BP> 220/120 or, if thrombolysis 
planned, BP> 185/110 mmHg). 
 Maintenance of Intravascular volume with isotonic fluids. 
Osmotic therapy with mannitol may be necessary to control 
edema in large infarcts, but isotonic volume must be replaced to 
avoid hypovolemia. 
 In cerebellar infarction (or hemorrhage), rapid deterioration can 
occur from brainstem compression and hydrocephalus, 
requiring neurosurgical intervention. 
THROMBOLYSIS AND ENDOVASCULAR TECHNIQUES: 
 IV rTPA is used for acute ischemic strokes of less than three 
hours duration without any evidence of hemorrhage. Recent 
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data support the use of IV rtPA for deficits of 3-4.5 h 
duration.
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ANTIPLATELET AGENTS: 
 Aspirin in doses upto 300mg has been found safe and is 
beneficial in acute ischemic stroke. 
ACUTE INTRACEREBRAL HEMORRHAGE: 
 Rapidly identify and correct any coagulopathy. 
 Stuporous or comatose patients generally are treated 
presumptively for elevated ICP. Treatment for edema and 
mass effect with osmotic agents may be necessary; 
glucocorticoids not helpful. 
 Neurosurgical consultation should be sought for possible 
urgent evacuation of cerebellar hematoma; in other 
locations, data do not support surgical intervention. 
COMPLICATIONS AFTER STROKE: 
ACUTE COMPLICATIONS 
- Raised intracranial pressure and herniation 
- Aspiration and pneumonia 
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COMPLICATIONS OF IMMOBILITY 
- Pneumonia 
- Contractures 
- Deep vein thrombosis 
- Bed sores 
- Urinary tract infections 
- Constipation 
LATE COMPLICATIONS 
- Depression 
- Epilepsy 
- Thalamic pain 
- Social problems 
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NATIONAL INSTITUTESOF HEALTH STROKE SCALE 
(NIHSS) 
It is a scale used to quantify objectively the severity of a 
stroke. NIHSS has 11 parameters. Each parameter has a score 
between 0 and 4 with 0 denoting normal function and higher scores 
indicating higher level of impairment. Scores of each parameter are 
added up to derive at the patient’s NIHSS score. Range of NIHSS 
is 0(minimum) to 42(maximum). 
  The scale is a simple bed side tool which is reliable 
and can be easily used by doctors and paramedics. Many studies 
have shown that increased NIHSS score was associated with an 
increased risk of neurological and medical complications. 
The NIHSS is an excellent and validated tool to predict 
patient outcomes. NIHSS scores correlate well with the volume of 
damaged brain. 
The components of the NIHSS is as the following: 
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NEUROCARDIOLOGY 
It had been always the heart to which attention was paid in 
cases of stroke, either as a source of embolism or cause of 
hypoperfusion. Recent turn is in the emphasis towards the 
mechanisms involving the brain injury as a cause for cardiac 
dysfunctions. 
When an acute ischemic/thrombotic stroke happens in any 
patient with underlying heart disease, the damage is severe. The 
auto regulation of blood flow is lost in the ischemic penumbra as 
the main factor which determines it, ‘the cardiac function’ is under 
stake.
 
Over the past fifty years lot of studies had been done to 
demonstrate various cardiac complications occurring in acute 
stroke. These include ECG changes like QTc prolongation, ST-T 
changes, septal U waves, LAD. These changes were more observed 
after a hemorrhagic stroke especially SAH,
 16-22
 but also seen to 
occur in ischemic strokes. 
A number of neurosurgical studies have shown that ECG 
abnormalities and left ventricular dysfunction (wall motion 
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hypokinesias) can occur in hemorrhagic stroke especially SAH.
23-26
 
Also described are myocardial stunning and myocardial necrosis. 
Other findings were increased levels of natriuretic factors, 
catecholamines in the plasma. Myocardial perfusion too gets 
affected regionally.
27-30 
The insular cortex had been studied and found to cause 
cardiac sympathetic neural upregulation and ECG 
abnormalities.
31
In a recent animal study it has been found that the 
left insular cortex related to parasympathetic cardiac and 
vasomotor function whereas the right insula is concerned with the 
sympathetic cardiac and vasomotor control.  
Also, SAH on the right side involving the Sylvian fissure 
had been found to be associated with cardiac complications.
32-
36
Thus any insult to the right insula either directly or indirectly can 
lead to consequences like sudden cardiac death after stroke.
56-59 
Regardless of the presence of pre-existing heart disease, ST 
segment and T wave changes, QT prolongation, and ventricular 
and supraventricular tachyarrhythmias are common ECG 
manifestations of stroke. In addition, greater variability of systolic 
blood pressure has been noted in patients with acute stroke 
compared with controls. 
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Centrally mediated sympathetic hyperactivity, reduced 
cardiac parasympathetic innervation and abnormal baroreceptor 
function have been proposed to be the causes for these findings. In 
animal studies it has been shown that the levels of circulating 
catecholamines are elevated during acute stroke.
37-39 
Reactive oxygen species are abundantly  generated during 
acute ischemic stroke. There is a good body of evidence indicating 
that oxidative stress is a pivotal mediator of tissue injury in acute 
ischemic stroke. 
      Cerebral autoregulation is the phenomenon by which 
maintaining the cerebral blood flow at a relatively constant rate 
despite variations in perfusion pressure. The mechanism by which 
auto-regulation occurs is not well understood, and may involve 
multiple pathways. 
                      There are evidences which suggests that the smooth 
muscle in cerebral vessels can respond directly to changes in 
perfusion pressure, contracting when pressure increases and 
relaxing when pressure decreases. Reductions in cerebral blood 
flow may lead to cerebral vasodilatation due to release vasoactive 
substances, although the substance responsible for this have not 
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been identified. Nitric oxide which releasing from vascular 
endothelium appears to play a role in autoregulation. 
Abnormal Calcium Modulation in Heart Disease: 
 Heart failure and cardiac hypertrophy can lead to systolic 
and diastolic dysfunction. One of the important mechanisms is 
defects in intracellular calcium modulation.  
 There is a highly positive correlation between end-diastolic 
calcium levels and diastolic relaxation abnormalities. The duration 
of diastole is prolonged in most models of congestive heart failure. 
This change has been found to be associated with transient 
intracellular calcium. However, marked increase in systolic and 
diastolic calcium occurs in myocardial ischemia and yet this is not 
coupled with the chronotropic effects which gets decreased. Hence, 
ischemia and decreased responsiveness of myofilament to calcium 
may affect both systolic force generation and diastolic relaxation. 
Sarcolemmal receptors and mechanisms:  
The cardiac sarcolemma is a complex structure that contain 
multiple receptors (adrenergic and others), channels exchanges and 
pumps that are necessary for maintaining cellular homeostasis. 
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Aspects of normal sarcolemmal function are impaired in the failing 
heart. 
Synergistic interactions between an increase in Cytosolic 
Calcium (Ca(I)
2+
) and a decrease in adenosine triphosphate (ATP) 
availability increase diastolic tension and can cause an exacerbate 
diastolic dysfunction. 
Effect of hormones: 
 Weber et al had presented an interesting study incriminating 
aldosterone as one of the stimulus of myocardial fibrosis. Brain 
natriuretic peptide levels have been found in relation to the 
decrease in LV mass index as well as diastolic function. In 
Hypertensive patients, this peptide can be an indicator of 
ventricular remodeling. The octapeptide angiotensin II definitely 
plays a central role in LV remodeling by promoting the growth of 
cardiac myocyte. 
Renin angiotensin system and endothelial system may play a role 
in the development of hypertrophy, ventricular fibrosis and 
eventually diastolic failure. This had been found to occur in 
hypertensive patients. Endothelin system also has a role in causing 
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this effect. Thus, there is robust evidence suggesting that acute 
brain injury alters the autonomic regulation of the cardiovascular 
system. 
T-WAVE CHANGES DUE TO VARIOUS CAUSES 
 
 The deep T wave inversions are to be differentiated among 
various causes.  
 The T wave inversion in the picture row of CVA is caused 
by an SAH and is characterized by the marked prolongation 
of QT interval.  
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ATRIAL FIBRILLATION 
 
Recent data suggest that a focal mechanism plays a role and 
it involves both increased automaticity and multiple re-entrant 
wavelets which occurs mainly in the left atrium around the 
pulmonary veins.  
Characteristically, P waves are absent. There is chaotic atrial 
activity and fibrillatory (F) waves are present. 
Ventricular rhythm is usually irregularly irregular. If AF is 
suspected with a regular ventricular response then the possibility of 
a heart block with junctional or ventricular escape should be 
considered. 
Common causes of AF include 
 Old age  
 Hypertension  
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 Valvular heart disease 
 Congestive heart failure  
 Coronary artery disease 
 Hyperthyroidism 
 Drugs 
 Chronic lung disease 
 Post cardiac surgery 
QT INTERVAL 
In a standard surface electrocardiogram the QT interval 
includes the QRS complex, ST segment and the T wave 
corresponding to phases 0 to 3 of action potential.
 
QT dispersion has been defined as inter lead variability (difference 
between maximum and minimum QT interval). Increased QT 
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dispersion is a direct reflection of disparity in myocardial recovery. 
Thus determination of QT dispersion may help to predict 
arrhythmogenicity in patients with acute cerebrovascular accident. 
Homogeneity of ventricular recovery is considered to be protective 
against ventricular arrhythmias. On the contrary, dispersion of 
recovery is considered to be arrhythmogenic. 
Measurement of QT interval and QT dispersion: 
QT interval is measured from beginning of QRS complex to 
the end of T wave. The presence of a U wave is not included in 
measuring QT interval. 
Corrected QT interval: 
The QT interval is affected by heart rate. It is longer when 
the heart rate is slow and shorter when the heart rate is fast, so the 
QT interval should be corrected for heart rate. 
The most frequently used formula for correcting QT interval for 
heart rate is the Bazett’s formula. Corrected QT interval is QT 
interval (in seconds) divided by the square root of preceding RR 
interval (in seconds). 
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A prolonged QT interval is defined as 
 >0.44 seconds in men 
>0.46 seconds in women and children 
>0.50 seconds (if there is bundle branch block or 
intraventricular conduction delay). 
Various studies have found that QT dispersion varies between 30 
and 60 milliseconds in normal population. A QTcd of more than 70 
milliseconds is considered abnormal. 
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ECHOCARDIOGRAM 
INTRODUCTION: 
 Echocardiogram is safe, non-invasive, and repeatable and 
allows visualization of structures and thus assesses the anatomical 
and hemodynamic activity in the cardiovascular system. 
Echo has become the most important tool for diagnosis of 
structural and functional abnormalities of the heart. Anatomic 
details can be accurately portrayed and cardiac structures can be 
measured and their movements traced throughout the cardiac cycle. 
COMPONENTS 
 TRANSDUCER: is a probe housing piezoelectric elements. 
These elements have the property of changing shape when 
electrical current is applied and vice versa. Phased array sector 
transducer is used. 
 TRANSMITTER: produces the impulse that is to be sent to the 
transducer. Also known as 'pulser'. 
 RECEIVER: receives the current produced in the transducer 
from the sound energy that returns. 
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 AMPLIFIER: amplifies the signals which returns and processes 
them for display in the monitor. 
ULTRASOUND WAVE: 
 Ultrasound travels through soft tissues of the body at particular 
speeds and as it travels ultrasonic wave is progressively 
attenuated. 
 The ultrasound wave is either reflected, scattered or absorbed 
depending on the properties the different tissues in the body. 
 Frequency is number of cycles in one sec (i.e) number of times 
the piezoelectric crystal vibrates (expands and contracts). 
 Period is the length of time to complete one cycle. 
 Relationship between transducer frequency and tissue 
penetration 
-Penetration is inversely related to frequency. 
RESOLUTION: 
As in the field of optics resolution is defined as the smallest 
distance between two points at which they can still be depicted as 
separate. 
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Any area of interest may be displayed both in longitudinal and 
cross-sections. 
The quantity of the image produced depends on the image 
resolution. 
TYPES  
-Axial resolution: of the transducer is spatial resolution along the 
axis of the sound beam, also known as range, depth or longitudinal 
resolution. 
-Lateral Resolution: is transverse resolution and is perpendicular to 
the axis of the sound beam, also known as azimuthal and angular 
resolution and depends on beam diameter. 
MODES OF DISPLAY: 
The echo returning to the transducer may be presented on the 
display in several different forms. 
 A-mode: Amplitude mode echoes are presented as vertical 
spikes on a baseline the height of the spike represents the 
amplitude of the returning echoes and bases line represents the 
depth. 
53 
 
 B-mode: Brightness mode. The brightness of the dot represents 
the amplitude of the returning echoes. 
 M-mode: is the motion mode. The two display parameters in an 
M-mode trace are distance from transducer and time. The 
pattern of movement represents the motion of the structure over 
a specific time interval. 
 2-D Mode: 2 dimensional display of scanned anatomy 
providing tomographic views. But reduction in temporal 
resolution, requires M-mode to complement this mode in cases 
of fast moving structures and precise timing of events. 
 Doppler principle is used for assessment of blood flow. 
DOPPLER ECHOCARDIOGRAPHY 
A modality that gives a hemodynamic assessment of the heart. 
Based on Doppler principle that the frequency of sound increases 
or decreases as it moves closer or farther from the observer. 
 PW (pulsed-wave) and CW (continuous wave) are spectral 
analysis modes. PW mode is used to assess low velocity flow in 
specific areas. CW mode is used to assess high velocity flow 
 Color flow imaging. Helps assess intracardiac blood velocity. 
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 TDI (Tissue Doppler Imaging) Used as an adjunct in assessing 
LV diastolic function. 
 CMM (colour M mode) 
COLOURDOPPLER  
 
The dots indicate multiple sampling sites (gates). The 
frequency shift measured at each gate is correlated automatically 
(autocorrelation) and converted toa preset color scheme (red for 
flow toward and blue for flow away from the transducer). 
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DIFFERENT VIEWS USED IN ECHOCARIOGRAPHY 
          
  
PARASTERNAL VIEWS 
Left sternal border approach is called parasternal view. Long and 
short axis views are taken in the parasternal position. 
Long Axis (PLAX): 
Transducer beam positioned to slice the heart in its long axis from 
the apex to its base. Marker is directed towards the right shoulder 
of the patient. This view demonstrates the long section through the 
SUPRASTERNAL 
PARASTERNAL 
SUBCOSTAL 
APICAL 
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LV, LA, mitral leaflets, aortic root, aortic cusps and a small section 
of the RV. 
Short Axis (PSAX): 
This place is perpendicular to the LAX plane and is obtained by 
rotating the transducer 90
0
 from the LAX plane and the marker is 
directed towards the left shoulder of the patient. 
APICAL VIEWS 
Apical 4 – Chamber View: 
Obtained by placing the transducer at the apex, with the marker 
directed towards the left shoulder and beam parallel to the plane of 
the left shoulder and right hip. 
Apical 5 – Chamber View: 
Obtained with the transducer in the apical position and tilting the 
transducer antero-superiorly, thus visualizing the LV outflow tract 
and the aortic root. 
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SUMMARY OF VARIOUS VIEWS 
 
 
  
PLAX view 
RV INFLOW 
Tract view 
PSAX view 
APICAL 2C view 
APICAL 4C view 
SUPRASTERNAL 
long axis 
SUPRASTERNAL 
short axis 
SUBCOSTAL 
4C view 
SUBCOSTAL 
short axis 
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Apical 2-Chamber View: 
Obtained by rotating the transducer 90
o
 anti-clockwise, from the 
routine 4 chamber view. 
SUBCOSTAL VIEWS: 
 It has two views namely four chamber and short axis view 
SUPRASTERNAL VIEWS: 
The transducer is placed in suprasternal notch to see the aortic arch 
and its branches. The marker is directed towards the left ear of the 
patient. 
It again has a long and short axis viewing 
M-MODE EXAMINATION: 
M-mode records cardiac motion at a high frame rate, thus helps 
better appreciation of subtle changes in valvular or wall motion. 
COLOR DOPPLER: 
Makes it possible to visualize and quantify blood flow in the heart. 
Colors represent direction & velocity of blood flow. 
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EVALUATION OF SYSTOLIC AND DIASTOLIC FUNCTION 
SYSTOLIC FUNCTION 
There are many parameters which could be used to express systolic 
function by echocardiography.  
 LV Ejection fraction 
 Stroke volume & Cardiac index 
 Fractional shortening  
 Systolic tissue velocity of the mitral annulus and 
myocardium 
 Strain 
 Regional wall motion defects 
LV Ejection fraction 
 It is the most commonly used parameter to assess to assess 
global LV function. 
It has many limitations, yet it is very good prognostic marker in 
various cardiac diseases and it is useful in determining the optimal 
treatment strategies in a given clinical cardiac condition. It has a 
significant inter-observer variability. Hence should be performed 
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more objectively as far as possible using the following volumetric 
parameters. 
(LV end-diastolic volume - LV end-systolic volume) 
EF =-------------------------------------------------------------- 
LV end-diastolic volume 
Fractional shortening  
It is the change in the LV dimension percentage with each 
contraction of the ventricle. 
  (LVend-diastolic dimension – LV end-systolic dimension) 
       FS = ----------------------------------------------------------------- 
          LV end-diastolic dimension 
Stroke volume 
It can be measured by obtaining the difference between LVEDV 
and LVESV measured by Simpson’s method or 3D echo. 
MEASUREMENT SITES OF LEFT VENTRICULAR DIMENSION 
(American society of Echocardiography) 
 
PSAX view PLAX view 
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Simpson’s method  
Measurement of LV volume by the biplane Simpson method 
needs two orthogonal apical views, namely the 4C and 5C views. 
The left ventricle is divided into 20 cylinders or discs. Their 
volumes are calculated and added to provide LV volume at end 
diastole (LV EDD) and end systole (LV ESD). 
 
LVEDD- left ventricular end diastolic dimension 
LVESD- left ventricular end systolic dimension 
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TWO-DIMENSIONAL GUIDED M-MODE ECHOCARDIOGRAM 
OF LEFT VENTRICLE (LV) AT THE PAPILLARY MUSCLE 
LEVEL 
 
In this echo window, the LV end-diastolic internal 
dimension (EDd) measured at the onset of QRS is 60 mm, and the 
LV end-systolic internal dimension (ESd) is 38 mm. 
Ef is calculated from the formula discussed above. 
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DIASTOLIC FUNCTION 
 Assessment of diastolic function is important because almost half 
of the patients with heart failure can have a normal LVEF. 
Echocardiography using 2D, M-mode and Doppler are useful in 
determining the diastolic function. 
STEPS TO ASSESS DIASTOLIC DYSFUNCTION 
1. Evidence of LVDD in M-mode and 2D echo. Abnormal 
relaxation leads to decrease in the slope (M-mode), decreased 
motion of the mitral annulus during early diastole and increase 
in the size of left atrium 
2. Velocity at the mitral inflow. This reflects transmitral pressure 
gradient and useful in staging diastolic dysfunction. 
3. Myocardial relaxation (by TDI), Mitral annulus velocity (E’). 
4. Mitral inflow velocity (E and A). E-early diastole ; A-late 
diastole 
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GRADING OF DIASTOLIC DYSFUNCTION 
Grade:1 (mild dysfunction)-Ventricular relaxation is impaired but 
filling pressures  are normal. Hence Mitral E velocity is decreased 
and A velocity is increased, producing an E/A ratio of less than 1, 
with prolonged DT(Dispersion time). 
Grade:2 (moderate dysfunction)- also called as pseudonormalized 
mitral flow filling pattern. Due to this the E/A is 1 to 1.5 and DT 
normal (160 to 240 ms). This pseudonormalisation happens 
because of raised LA pressure.  
How to differentiate this from true normal? 
1. E’<7 
2. Presence of mid-diastolic flow 
3. Increase in A with Valsalva manouvere 
Grade: 3-4 (severe diastolic dysfunction) –also called as restrictive 
filling. It can be caused by any condition leading restrictive 
physiology. 
E/A ratio >2, and shortened DT (<160 milliseconds) 
Intraventricular relaxation time IVRT (<70 milliseconds) 
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MATERIALS AND METHODS 
SETTING OF THE STUDY: 
This study was conducted at the Institute of Internal Medicine, 
Madras Medical College and Rajiv Gandhi Government General 
Hospital, Chennai. 
ETHICS COMMITTEE APPROVAL: 
 Obtained from the Institutional ethics committee. 
STUDY POPULATION: 
 Patients admitted with acute ischemic/thrombotic stroke in the 
medical wards of our Institute. 
STUDY DURATION: 
 This study was conducted over six months. 
SAMPLE SIZE: 
 Hundred consecutive patients admitted with acute 
ischemic/thrombotic stroke. 
TYPE OF STUDY: 
Observational (prospective and retrospective) 
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INCLUSION CRITERIA: 
 Patients presenting within 24 hours of symptom onset and 
diagnosed with acute ischemic/thrombotic stroke. 
EXCLUSION CRITERIA: 
 1. Age younger than 18 years 
2. Evidence of cerebral hemorrhage on initial head CT 
3. Resolution of neurologic symptoms within 24 hours 
4. Presence of documented chest pain 
SPONSORSHIP:  
No sponsorship was obtained to perform this study. 
CONFLICTS OF INTEREST: 
No 
DISCLOSURES: 
 No disclosures to mention, related to this study. 
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DATA COLLECTION AND METHODS: 
 Patients were selected carefully based on the inclusion and 
exclusion criteria 
 Informed consent was obtained from each patient or the relative 
 The clinical details were obtained based on a unique proforma 
(enclosed) prepared for this study 
 Clinical history was taken based on a questionnaire in the proforma 
 Patients were subjected to routine blood investigations 
(CBC/RFT/LFT), plain CT brain, 12 lead Electrocardiogram and 
Echocardiography at admission. 
 12 lead Electrocardiogram and Echocardiography were repeated at 
48 hours of admission. 
 During their stay, patients were monitored for arrhythmias and 
hemodynamic changes 
 LV systolic dysfunction and LV diastolic dysfunction, and ECG 
changes including ST-T changes (ischemic/non-ischemic) and 
arrhythmias, were taken as the prime variables in the study.
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 During echocardiography, systolic dysfunction was assessed with 
Four-chamber view which was used to record the LV volume and 
Ejection Fraction. 
 Systolic dysfunction was assessed based on Ejection fraction. 
Though this is could miss LV dysfunction with preserved ejection 
fraction, our aim in this study is only to detect early cardiac 
changes during acute stroke. 
 Diastolic dysfunction was assessed using Doppler 
echocardiography by integrating information obtained from pulsed-
wave Doppler of mitral inflow and pulmonary venous flow 
combined with 2D assessment of left atrial size. 
 Patients were grouped based on NIH stroke scale. 
 All the data were pooled from the proforma and master chart 
prepared. 
 Data were analyzed using SPSS package and chi square tests. 
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OSERVATION AND RESULTS 
As the sample size in our study is 100, separate mention about the 
percentages are made only where relevant. 
Table: 1   AGE DISTRIBUTION 
Age group Frequency 
<= 40 3 
41-50 17 
51-60 28 
61-70 27 
71-80 18 
> 80 7 
Total 100 
 
 
  
 
 
Majority of the population in the study fall in the 51 to 70 years 
age group. 
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The age distribution in our study takes the bell shaped curve 
pattern. To mention here again, age group less than 18 years were 
excluded from our study. 
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Table: 2 STROKE SEVERITY IN DIFFERENT AGE GROUPS 
 
Age (in years) P-
value NIHSS <40 41-50 51-60 61-70 71-80 >80 
5 to 15 2 14 15 8 5 3 
0.012* 15 to 20 1 3 7 5 7 1 
>20 0 0 6 14 6 3 
* - significant at 5 level 
 
The 50 to 70 age group has got higher proportion of ‘severe stroke’ 
group. Again, it is this age group which forms the bulk of our study. 
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Table: 3   SEX DISTRIBUTION 
SEX 
NIHSS 
5-15 16-20 > 20 
Sex Male 25 13 16 
 Female 22 11 13 
Total 47 24 29 
 
 
 
The study population group is fairly divided with sex. There was no 
significant difference in the stroke severity among sexes. 
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Table: 4   FREQUENCY TABLE OF RISF FACTORS 
 
 
 
In our study group, Hypertension was seen in 57% and Diabetes 
mellitus was seen in 31% of the patients. Hyperlipidemia (20%) and 
Alcohol consumption (13%) were the other common risk factors 
observed. 
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Table: 5   ARRHYTHMIAS (AT ADMISSION AND 48 HOURS) 
 
 ARRHYTHMIAS 
NUMBER admission 48 hours 
present 7 12 
absent 93 88 
 
 
A small proportion of 7% had arrhythmias at admission. The number 
increased to 12% at 48 hours of monitoring. This increase is although not 
statistically significant. 
0
20
40
60
80
100
7 
93 
12 
88 
N
u
m
b
er
 
Arrhythmias 
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at admission        and        48 Hours 
 
Present(admission) Absent(admission) Present(48 Hours) No(48 Hours)
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Table: 6   ARRYTHMIA TYPES 
Type Of Arrhythmia Number Percentage 
AF 11 92% 
VT 1 8% 
   
 
 
 Among the 12 patients who had rhythm disturbances, 11(92%) had 
atrial fibrillation and 1 patient (8%) developed ventricular tachycardia. 
  
AF, 11, 92% 
VT, 1, 8% 
Arrhythmia types 
AF VT
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Table: 7   ST-T CHANGES (AT ADMISSION AND 48 HOURS) 
                        ST-T CHANGES 
NUMBER admission 48 hours 
present 14 20 
absent 86 80 
 
 
In our study group, 14% had ST-T changes in the ECG at 
admission. This included only ischemic ST-T changes excluding non-
specific ST-T changes andST depression &T wave inversions seen in 
acute strokes. At 48 hours, 20% had these changes in the ECG. 
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Table: 8  LV SYSTOLIC DYSFUNCTION (AT ADMISSION AND 
48 HOURS) 
 LV systolic dysfunction 
Ejection Fraction admission 48 hours 
<40 12 24 
41-50 23 15 
>50 65 61 
 
 
In our study, 12% had EF<40% at admission and this number 
doubled to 24% at 48 hours echocardiography. 23% fell in the EF 41-
50% group at admission and 15% at 48 hours. More than 60% had normal 
LV systolic function based on the EF both at admission and 48 hours. 
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Table: 9    LV DIASTOLIC DYSFUNCTION (AT ADMISSION 
AND 48  HOURS) 
 LV diastolic dysfunction 
Grade admission 48 hours 
normal 57 54 
1 26 24 
2 14 13 
3 3 9 
 
 
In our study, 3% had Gr.3 LVDD at admission and the number 
rose to 9% at  48 hours. Around 25% had Gr.1 LVDD. Nearly half had 
normal LVDD. 
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Table: 10  NIH STROKE SEVERITY GROUPS 
NIH stroke scale frequency 
5-15 Moderate 47 
16-20 Moderate to severe 24 
>20 Severe 29 
 Total 100 
 
 
 
In our study, 47% patients had a moderate stroke, 24% had a moderate to 
severe stroke, and 29% had a severe stroke. 
NIH stroke severity groups 
80 
 
Table: 11  ST-T CHANGES WITH SEVERITY OF STROKE 
S
T
-T
 C
H
A
N
G
E
S
 
 NIHSS  
 5-15 16-20 >20 Total 
present 3 6 11 20 
absent 44 18 18 80 
    100 
 
 
 
In our study, 20 % had ST-T changes at the end of 48 hours and among 
them more than half (55%) belonged to the severe stroke group. Six 
patients (30%) belonged to the moderate to severe stroke group. 
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ST-T changes with Severity of stroke 
ST-T changes NIHSS
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Table: 12  SEVERITY OF LV SYSTOLIC DYSFUNCTION (at 
admission) AMONG STROKE SEVERITY GROUPS 
E
je
ct
io
n
 F
ra
ct
io
n
 (
%
) 
 NIHSS  p value 
 5-15 16-20 >20 total 
 
 
<0.001** 
>50 40 15 10 65 
41-50 6 8 9 23 
<40 1 1 10 12 
     100 
**- highly significant at 1 level. 
 
In our study, a total of thirty five patients had some degree of 
systolic LV dysfunction during admission. 
40 (61.5%) 
15 (23.1%) 10 (15.4%) 
6 (26.1%) 
8 (34.8%) 9 (39.1%) 
1 (8.3%) 1 (8.3%) 
10 (83.3%) 
0
5
10
15
20
25
30
35
40
45
5 to 15 15 to 20 >20
N
U
M
B
ER
 
NIHSS 
SYSTOLIC DYSFUNCTION(admission)and NIHSS 
EF(%) EF(%)
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In the systolic dysfunction group, twelve patients had an EF of less 
than 40% and ten (83.3%) amongst them belonged to the severe stroke 
group which is statistically highly significant.  
P value obtained was <0.001 
 Twenty three patients had mild LV systolic dysfunction and the 
proportion of them in severe stroke group was more though not 
statistically significant.  
  Sixty patients had normal LV systolic function and forty (61.5%) 
among them belonged to the moderate stroke group and this difference 
among severity groups is statistically highly significant. 
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Table: 13  SEVERITY OF LV SYSTOLIC DYSFUNCTION (at 48 
hours) AMONG STROKE SEVERITY GROUPS 
E
je
ct
io
n
 F
ra
ct
io
n
 
(%
) 
 NIHSS  p value 
 5-15 16-20 >20 total 
 
 
<0.001** 
>50 37 14 10 61 
41-50 7 4 4 15 
<40 3 6 15 24 
     100 
**- highly significant at 1 level. 
 
 
In our study, a total of thirty nine patients had some degree of 
systolic LV dysfunction at 48 hours. 
37 (60.7%) 
14 (23%) 
10(16.4%) 
7 (46.7%) 
4 (26.75) 4 (26.7%) 3 (12.5%) 
6(25%) 
15 (62.5%) 
0
5
10
15
20
25
30
35
40
5 to 15 15 to 20 >20
N
U
M
B
ER
 
NIHSS 
SYSTOLIC DYSFUNCTION(48hours) and NIHSS 
 
EF(%) EF(%)
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In the systolic dysfunction group at 48 hours, 24 patients had an EF 
of less than 40% and fifteen (62.5%) amongst them belonged to the 
severe stroke group which is statistically highly significant.  
P value obtained was <0.001 
 Sixty one patients had normal LV systolic function and thirty 
seven (60.7%) among them belonged to the moderate stroke group and 
this difference among stroke severity groups is statistically highly 
significant. 
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Table: 14  SEVERITY OF LV DIASTOLIC DYSFUNCTION (at 
admission) AMONG STROKE SEVERITY GROUPS 
L
V
D
D
 G
ra
d
e 
 NIHSS  p value 
 5-15 16-20 >20 total 
 
 
<0.001** 
normal 34 15 8 57 
1 10 8 8 26 
2 3 1 10 14 
3 0 0 3 3 
     100 
**- highly significant at 1 level. 
 
In our study, a total of forty three patients had some degree of LV 
diastolic dysfunction during admission. 
10 (38.5%) 
8 (30.8%) 8(30.8%) 
3 (21.4%) 
1(7.1%) 
10 (71.4%) 
0 0 
3 (100%) 
5 TO 15 15 TO 20 >20 
N
U
M
B
ER
 
NIHSS 
LV Diastolic dysfunction(at admission) 
and NIHSS 
LVDD LVDD LVDD
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In the LVDD group at admission, three patients had Grade 3 
LVDD and all 3 (100%) of them belonged to the severe stroke group 
which is statistically highly significant.  
P value obtained was <0.001 
 Fourteen patients had Grade2 LVDD and 10 of them (71.4%) 
belonged to severe stroke group which is statistically highly significant. 
(p<0.001)  
  Fifty seven patients had normal LV diastolic function and 34 
(59.6%) of them belonged to the moderate stroke group and this 
difference among severity groups is statistically highly significant. 
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Table: 15  SEVERITY OF LV DIASTOLIC DYSFUNCTION (at 48 
hours) AMONG STROKE SEVERITY GROUPS 
L
V
D
D
 G
ra
d
e 
 NIHSS  p value 
 5-15 16-20 >20 total 
 
 
<0.001** 
normal 33 13 8 54 
1 11 8 5 24 
2 2 3 8 13 
3 1 0 8 9 
     100 
**- highly significant at 1 level. 
 
In our study, a total of forty four patients had some degree of LV 
diastolic dysfunction at 48 hours. 
11 (45.8%) 
 
8 (33.3%) 
5 (20.8%) 
2 (15.4%) 
3 (23.1%) 
8 (61.5%) 
1(11.1%) 
0 
8 (88.9%) 
5 TO 15 15 TO 20 >20 
N
U
M
B
ER
 
NIHSS 
LV Diastolic dysfunction(48 hours) and 
NIHSS 
LVDD LVDD LVDD
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In the LVDD group at 48 hours, nine patients had Grade 3 LVDD 
and 8 (88.9%) of them belonged to the severe stroke group which is 
statistically highly significant.  
P value obtained was <0.001 
 Thirteen patients had Grade2 LVDD and 10 of them (61.5%) 
belonged to severe stroke group which is statistically highly significant. 
(p<0.001)  
  Fifty four patients had normal LV diastolic function and 33 
(61.1%) of them belonged to the moderate stroke group and this 
difference among severity groups is statistically highly significant. 
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Table:16 ST-T CHANGES ACROSS STROKE SEVERITY 
GROUPS (at median NIHSS 10) 
S
T
-T
  
ch
a
n
g
es
 
NIHSS total 
<10 >10  
2(10%) 18(90%) 20 
 
 
In our study, twenty patients had ST-T changes in their ECG at the 
end of 48 hours and among them 18 (90%) patients belonged to the 
NIHSS >10 group. 
  
2(10%) 
18 (90%) 
N
U
M
B
ER
 
ST-T changes  
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TABLE:17 ARRHYTHMIAS DISTRIBUTED ACROSS STROKE 
SEVERITY (at median NIHSS 10) 
A
rr
y
th
m
ia
s NIHSS total 
<10 >10  
1(8.3%) 11(91.7%) 12 
 
 
 
 In our study, twelve patients had ST-T changes in their ECG at the 
end of 48 hours and among them 11 (91.7%) patients belonged to the 
NIHSS >10 group. 
1 (8.3%) 
11 (91.7%) 
<10 >10 
N
U
M
B
ER
 
NIHSS 
Arrythmias 
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TABLE:18 ARRHYTHMIAS DISTRIBUTED ACROSS STROKE 
SEVERITY (at median NIHSS 10) 
E
F
<
5
0
%
 NIHSS total 
<10 >10  
5(87.2%) 34(12.8%) 39 
 
 
In our study, 39 patients had some degree of LVSD in the echo at 
the end of 48 hours and among them 34 (87.2%) patients belonged to the 
NIHSS >10 group. 
5 (12.8%) 
34 
(87.2%) 
<10 >10
N
U
M
B
ER
 
NIHSS 
SYSTOLIC DYSFUNCTION(EF<50%) 
ACROSS MEDIAN NIHSS 10 
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Table: 19  DISTRIBUTION OF MODERATE TO SEVERE LVSD 
ACROSS STROKE SEVERITY GROUPS 
N
IH
S
S
 
 
EF<40% 
p-value 
frequency percentage 
5 - 15 3 12.5 
0.008** 
16 - 20 6 25.0 
>20 15 62.5 
  24 100.0 
**- highly significant at 1 level 
 
This graph shows the rising trend of the moderate to severe LVSD 
curve across the stroke severity group. 15 patients(62.5%) fall in the 
severe stroke group. The difference in distribution is statistically highly 
significant. (p<0.001) 
3 
6 
15 
5 to 15 16 to 20 >20
N
U
M
B
ER
 
NIHSS 
LV SYSTOLIC DYSFUNCTION 
EF(%) <40 
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Table: 20  DISTRIBUTION OF GRADE 2-3 LVDD ACROSS 
STROKE SEVERITY GROUPS 
N
IH
S
S
 
 
LVDD Grade 2-3 
p-value 
frequency percentage 
5 - 15 1 11.1 
0.020* 
16 - 20 0 0 
>20 8 88.9 
  9 100.0 
*-  significant at 5 level 
 
This graph shows the rising trend of the Grade2-3 LVDD curve 
across the stroke severity group. 8 patients (88.9%) fall in the severe 
stroke group. The difference in distribution is statistically significant. 
(p<0.050) 
3 
6 
15 
5 to 15 16 to 20 >20
N
U
M
B
ER
 
NIHSS 
LV DIASTOLIC DYSFUNCTION (LVDD>2) 
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Table :21    SUMMARY OF CARDIAC MORBIDITY ACROSS 
STROKE SEVERITY 
N
IH
S
S
  ARRHYTHMIAS ST-T 
CHANGES 
EF<40% p-value 
<15 3 3 3 
<0.05* >15 9(81.81%) 17(85%) 21(87.5%) 
 total 11 20 24 
*- significant at 5 level 
 
 
     The graph above summarizes the incidence of cardiac complications in 
acute ischemic stroke. 
3 3 3 
9 
17 
21 
0
5
10
15
20
25
CARDIAC MORBIDITY AND STROKE SEVERITY 
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The number of patients with AF, ST-T changes and moderate to 
severe LV dysfunction are divided with an arbitrary median of NHISS 15. 
81.1% of AF, 85% of ST-T changes, 87.5% of significant LV 
systolic dysfunction were found in the ‘moderate to severe’ and ‘severe’ 
stroke groups (NIHSS>15). 
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RESULTS 
 The total sample size of our study is 100. All the patients selected 
met the inclusion and exclusion criteria.  
DEMOGRAPHICS 
 Demographic data of our study group is summarized in table 1 and 
table 2. 
 Age group distribution followed a bell shaped curve with majority 
(65%) of the population in 50 to 70 years of age. NIHSS severity 
among the age groups were more in the same age group. 
 6(20.2%) in the age group 51-60 and 14(48.2%) in the age group 
61-70 belonged to NIHSS>20 group 
 54% were males and 46% females. Study population had a fair sex 
ratio. 
RISK FACTORS 
 Of the 100 patients, 57 had hypertension, 31 had diabetes mellitus, 
20 had hyperlipidemia. 
 13 consumed alcohol, 12 had a history of CAD, 9 suffered heart 
failure and 5 had CKD 
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 Thyroid disease was seen in 4 patients and 2 patients had previous 
CVA. 
ARRYTHMIAS 
 7 patients had arrhythmias detected during admission and 12 
patients  had arrhythmias at the end of 48 hours 
 Of the 12 patients, 11 had Atrial fibrillation and 1 developed 
ventricular tachycardia 
 11 (91.7%) of those 12 patients who had arrhythmias also had an 
NIHSS>10 
ST-T CHANGES 
 14% had ST-T changes in the ECG at admission. 20% had ST-T 
changes in the ECG at 48 hours.  
 ST-T changes included onlyischemic changes excluding non-
specific ST-T changes andST depression &T wave inversions seen 
in acute strokes. 
 18 (90%) of those 20 patients who had ST-T changes had an 
NIHSS>10 
LV SYSTOLIC DYSFUNCTION 
 Systolic dysfunction was assessed based on Ejection fraction. 
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 12 patients had EF<40% at admission, and the number in this 
group increased to 24 at 48 hours 
 Patients with EF 41-50% at admission and 48 hours were 23 and 
15 respectively 
 Patients with EF>60 at admission and 48 hours were 65 and 61 
 In the systolic dysfunction group at admission, twelve patients had 
an EF of less than 40% and ten (83.3%) amongst them belonged to 
the severe stroke group which was statistically highly 
significant.(p<0.001) 
 In the systolic dysfunction group at 48 hours, 24 patients had an EF 
of less than 40% and fifteen (62.5%) amongst them belonged to the 
severe stroke group which is statistically highly 
significant.(p<0.001) 
 24 patients had an EF<40 at 48hours and 15 (62.5%) of them had a 
NIHSS>20 and 21 (87.5%) of them had a NIHSS>15, which is 
highly statistically significant. (p<0.010) 
LV DIASTOLIC DYSFUNCTION 
 17 patients had LVDD Gr.2 and 3 at admission , and the number in 
this group increased to 21 at 48 hours 
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 Patients with LVDD Gr1 at admission and 48 hours were 26 and 
24 respectively. 
 Patients with normal diastolic function at admission and 48 hours 
were 57 and 54. The seeming reduction in number is due to shift to 
severe LVDD groups. 
 In the LVDD group at admission, three patients had Grade 3 
LVDD and all 3 (100%) of them belonged to the severe stroke 
group which is statistically highly significant (p<0.001) 
 In the LVDD group at 48 hours, nine patients had Grade 3 LVDD 
and 8 (88.9%) of them belonged to the severe stroke group which 
is statistically highly significant. (p<0.001) 
 In total, 9 patients had an LVDD Gr2 and 3 and 8 (88.9%) of them 
had a NIHSS>20 which is statistically significant. (p<0.050) 
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DISCUSSION 
 There had been a constant emphasis on the complex 
relationship between cerebrovascular accidents and cardiovascular 
diseases. Many studies had been made in this context. Yet, the 
studies varied in many aspects and laid importance on one aspect 
out of the many complex manifestations involved with 
cardiovascular and cerebrovascular systems.  
 A number of studies in the past have concentrated upon the 
varied ECG manifestations occurring   in acute CVA including 
both ischemic and hemorrhagic. But whether similar effects cause 
significant damage in ischemic/thrombotic stroke has been less 
studied. The insular cortex had been studied and found to cause 
cardiac sympathetic neural upregulation and ECG abnormalities.  
A number of neurosurgical studies have shown that ECG 
abnormalities and left ventricular dysfunction (wall motion 
hypokinesias) can occur in hemorrhagic stroke especially SAH.
40-
43
Also described are myocardial stunning and myocardial necrosis. 
Other findings were increased levels of natriuretic factors, 
catecholamines in the plasma. Myocardial perfusion too gets 
affected regionally.
42-43
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 When an acute ischemic/thrombotic stroke happens in any 
patient with underlying heart disease, the damage is severe.
44-45
 The 
autoregulation of blood flow is lost in the ischemic penumbra as 
the main factor which determines it, ‘the cardiac function’ is under 
stake.
46
 
 In our study, the results are similar to that available in the 
literature, which suggests that the incidence of systolic dysfunction 
in acute ischemic/thrombotic stroke patients can range from 14% to 
30%. 
ST-T CHANGES 
Some studies also throw light on the ischemic changes in ECG 
which claims a range of 36% to 74% in hemorrhagic strokes. 
‘Oppenheimer et al’ in their study observed an incidence of 15-
20% after ischemic stroke. In our study, 20 patients had ischemic 
changes in the ECG. The incidence goes in hand with the literature. 
And also 18 out of 20 had a NIHSS>10 
These changes occur due to a neural mechanism and not associated 
CAD. 
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SYSTOLIC DYSFUNCTION 
24 patients had an EF<40 at 48hours and 15 (62.5%) of them had a 
NIHSS>20 and 21 (87.5%) of them had a NIHSS>15, which is 
highly statistically significant. (p<0.010) 
The incidence of 24% found in our study is similar to that quoted 
in other studies in this domain.
 
A similar study by ‘Wira et al’ observed a systolic dysfunction of 
28.5% 
In our study, the study design did not include a control group nor 
was echocardiography repeated in the follow up period in all the 
patients. Hence, whether the systolic dysfunction is a transient one 
or a pre-existing one could not be ascertained. Yet from the 
demographics of our study, it is found that only 9 patients had 
preexisting heart failure. So, the possibility of a temporal 
association of the systolic dysfunction and acute ischemic stroke is 
definitely feasible.
50-52
 Nevertheless, from our study we found that 
systolic dysfunction correlated well with the NIHSS severity as 
similar correlations with mortality were observed in other studies.
54 
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ARRHYTHMIAS 
 11 patients in our study had atrial fibrillation. One patient 
had a VT. About atrial fibrillation there only one study
53
 which 
proposes AF as a predictor of mortality. In our study 11 out of 12 
patients had an NIHSS>10 which is an indirect predictor of 
mortality. The exact mechanisms of how mortality is increased is 
poorly understood. 
An NIHSS of 10 is chosen as a comparing destination point 
because few studies in the literature have found that the excellent 
prognosis rate decreases significantly when the NIHSS is more 
than 10. 
All these changes are associated with increased mortality 
which was reflected in our study by the severity of NIHSS. Death 
was not taken as an 
 outcome in our study. 
A study of stroke patients had shown that left insular cortical 
lesions are more likely to produce ECG abnormalities and cardiac 
sympathetic neural upregulation. Such changes can lead to 
increased cardiac mortality which can be a major cause of mortality 
in stroke.
47-49 
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LIMITATIONS 
 Our study is limited by its sample size which is small. 
 The study design did not include a control group nor was 
echocardiography repeated in the follow up period in all the 
patients. Hence, whether the systolic dysfunction is a transient one 
or a pre-existing one could not be ascertained. 
Higher rate of systolic dysfunction were not compared with 
age matched controls. Yet from the demographics of our study, it is 
found that only 9 patients had preexisting heart failure. So, the 
possibility of a temporal association of the systolic dysfunction and 
acute ischemic stroke is definitely feasible.  
Nevertheless, from our study we found that systolic 
dysfunction correlated well with the NIHSS severity as similar 
correlations with mortality were observed in other studies. Yet, this 
is a considerable finding warranting further studies. 
Another limitation is that, in our study we did not control for 
other factors affecting LV function and any other previous 
medications which would affect the LV function during the time of 
performing the echocardiography. 
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CONCLUSION 
 A subset of patients who suffer acute ischemic/thrombotic 
stroke develop an array of cardiac complications. 
 These cardiac manifestations are either caused directly by the 
neural effects or other reasons not within the scope of this 
study. 
 Active atrial fibrillation, ischemic changes in the ECG, Left 
ventricular systolic and diastolic dysfunction are associated 
more with moderate to severe and severe stroke groups. 
 Thus these subset of patients may be associated with higher in 
hospital mortality rates and poor outcomes. 
 This study emphasizes the role of cardiac monitoring in the 
acute stroke setting. 
 Further studies can throw light on cardiac augmentation 
strategies, which could be adopted in the management protocol 
of acute ischemic/thrombotic stroke patients. 
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PROFORMA 
 
Study: CARDIAC COMPLICATIONS IN ACUTE ISCHEMIC/ 
THROMBOTIC STROKE WITH SPECIAL REFERENCE TO 
VENTRICULAR DYSFUNCTION. 
 
Name:       Patient ID No. : 
Age/Sex: 
IP No.: 
 
Risk factors 
 Diabetes mellitus  Hyperlipidemia  
 Hypertension  CKD 
 Heart failure  Thyroid disorder 
 Alcoholism   Previous CVA/ TIA 
 
 
Clinical parameters 
 At admission At 48 hours 
Pulse    
BP   
 
 
CNS examination: 
 
 
 
 
Investigations: 
CBC RFT LFT 
Hb  Glucose  mg/dl T.Bili  mg/dl 
Hct  Urea  mg/dl D.Bili  mg/dl 
TC  Creat.  mg/dl SGOT  U/l 
DC-N 
     -L 
     -E 
 Na
+ 
 mEq/l SGPT  U/l 
 K
+ 
 mEq/l ALP  U/l 
    T.Protein  g/dl 
Platelet     Albumin  g/dl 
 
CT brain(plain): 
 
 
 
Echocardiography 
 At admission At 48 hours 
EF%   
LVDD   
 
 
ECG 
 At admission At 48 hours 
Ischemic changes   
Arrhythmias    
 
 
  
NIH Stroke scale: 
 
 Neurological examination Score 
1a. Level of consciousness  
1b. LOC questions   
1c. LOC commands  
2. Best gaze  
3. Visual   
4. Facial palsy  
5a. Motor arm  (L)  
5b. Motor arm  (R)  
6a. Motor leg   (L)  
6b. Motor leg   (R)  
7. Limb ataxia  
8. Sensory   
9. Best language  
10. Dysarthria   
11. Extinction and Inattention   
 
TOTAL SCORE 
 
 
  
INFORMATION SHEET 
 
Study Title : CARDIAC COMPLICATIONS IN ACUTE ISCHEMIC 
/ THROMBOTIC STROKE PATIENTS WITH 
SPECIAL REFERENCE TO VENTRICULAR 
DYSFUNCTION 
Study Centre : Rajiv Gandhi Government General Hospital, Chennai. 
Patient’s Name/Age :  
Investigators Name :  
Identification 
Number 
:  
 
 We are conducting a study on “CARDIAC COMPLICATIONS IN ACUTE 
ISCHEMIC / THROMBOTIC STROKE PATIENTS WITH SPECIAL 
REFERENCE TO VENTRICULAR DYSFUNCTION” among patients 
attending Rajiv Gandhi Government General Hospital, Chennai and for that 
your specimen may be valuable to us. 
 The purpose of this study is we are selecting certain patients affected with 
stroke and if you are found eligible, we will perform an ecg and 
echocardiography(which are non-invasive tests) to assess your cardiac status. 
Apart from routuine blood examination,we may perform extra tests and special 
studies which in any way do not affect your final report or management. 
 The privacy of the patients in the research will be maintained throughout the 
study. In the event of any publication or presentation resulting from the 
research, no personally identifiable information will be shared. 
 Taking part in this study is voluntary. You are free to decide whether to 
participate in this study or to withdraw at any time; your decision will not result 
in any loss of benefits to which you are otherwise entitled. 
 The results of the special study may be intimated to you at the end of the study 
period or during the study if anything is found abnormal which may aid in the 
management or treatment. 
 
Signature of Investigator Signature of Participant 
         Date : 
 
PATIENT CONSENT FORM 
 
Study Title : CARDIAC COMPLICATIONS IN ACUTE ISCHEMIC 
/ THROMBOTIC STROKE PATIENTS WITH 
SPECIAL REFERENCE TO VENTRICULAR 
DYSFUNCTION 
 
Study Centre : Rajiv Gandhi Government General Hospital, Chennai. 
Patient’s Name/Age :  
Investigators Name :  
Identification 
Number 
:  
 
 I confirm that I have understood the purpose of procedure for the above study. 
I have the opportunity to ask question and all my questions and doubts have 
been answered to my complete satisfaction. 
 I understand that my participation in the study is voluntary and that I am free 
to withdraw at any time without giving reason, without my legal rights being 
affected. 
 I understand that sponsor of the clinical study, others working on the 
sponsor’s behalf, the ethical committee and the regulatory authorities will not 
need my permission to look at my health records, both in respect of current 
study and any further research that may be conducted in relation to it, even if I 
withdraw from the study I agree to this access. However, I understand that my 
identity will not be revealed in any information released to third parties or 
published, unless as required under the law. I agree not to restrict the use of 
any data or results that arise from this study. 
 I agree to take part in the above study and to comply with the instructions 
given during the study and faithfully cooperate with the study team and to 
immediately inform the study staff if I suffer from any deterioration in my 
health or well being or any unexpected or unusual symptoms. 
 I hereby consent to participate in this study. 
 I hereby give permission to undergo hematological test. 
 
Signature of Investigator           Signature of Participant 
 
Date:
Bµõ´a] uPÁÀ uõÒ 
 CµõãÆ Põ¢v Aµ_ ö£õx ©¸zxÁ©øÚUS Á¸® “ø»°À Cµzu 
SÇõ´ Aøh¨¤ÚõÀ HØ£k® £UPÁõu® EÒÍ ÷{õ¯õÎPÐUS 
EshõS® C¸u¯ £õv¨¦PøÍ AÔÁ÷u” CÆÁõµõ´a]°ß 
÷{õUP©õS®. 
 
 }[PÒ C¢u Bµõ´a]US uSv¯õÚÁµõ´ C¸US©õÚõÀ 
E[PÐøh¯ C¸u¯zvß |ø»ø¯ Cu¯zxi¨¦ £vÂ  (ECG) 
©ØÖ® ªß J¼ Cu¯ ÁøµÂ  (Echocardiography) £¶÷\õuøÚPÒ »® 
AÔ÷Áõ®. 
 
 C¢u Bµõ´a]°À ÁÇUP©õP ö\´²® Cµzu £¶÷\õuøÚPÐhß 
]» ]Ó¨¦ Cµzu £¶÷\õuøÚPøÍ ö\´x Auß uPÁÀPøÍ 
AÔ÷Áõ®. 
 
 }[PÐ® C¢u Bµõ´a]°À £[÷PØP {õ[PÒ Â¸®¦Q÷Óõ®. 
AuÚõÀ u[PÍx ÷{õ°ß B´ÁÔUøP÷¯õ AÀ»x ]Qaø\÷¯õ 
£õv¨¦US Em£hõx Gß£øu²® öu¶ÂzxU öPõÒQ÷Óõ®. 
 
 ¬iÄPøÍ AÀ»x P¸zxUPøÍ öÁÎ°k®÷£õ÷uõ AÀ»x 
Bµõ´a]°ß ÷£õ÷uõ u[PÍx ö£¯øµ÷¯õ AÀ»x 
Aøh¯õÍ[PøÍ÷¯õ öÁÎ°h©õm÷hõ® Gß£øu²® öu¶ÂzxU 
öPõÒQ÷Óõ®. 
 
 C¢u Bµõ´a]°À £[÷PØ£x u[PÐøh¯ Â¸¨£zvß ÷£¶À 
uõß C¸UQÓx. ÷©¾® G¢÷{µ¬® C¢u Bµõ´a]°¼¸¢x ¤ß 
Áõ[P»õ® Gß£øu²® öu¶ÂzxU öPõÒQ÷Óõ®. 
 
 C¢u ]Ó¨¦¨ £¶÷\õuøÚPÎß ¬iÄPøÍ Bµõ´a]°ß ÷£õx 
AÀ»x Bµõ´a]°ß ¬iÂß ÷£õx u[PÐUS AÔÂ¨÷£õ® 
Gß£øu²® öu¶ÂzxU öPõÒQ÷Óõ®. 
 
Bµõ´a]¯õÍº øPö¯õ¨£®   £[÷PØ£õÍº øPö¯õ¨£® 
 
÷uv :  
Bµõ´a] J¨¦uÀ Piu® 
 
Bµõ´a] uø»¨¦: 
 Cµzu SÇõ´ Aøh¨¤ÚõÀ HØ£k® £UPÁõu® EÒÍ 
÷{õ¯õÎPÐUS EshõS® C¸u¯ £õv¨¦PøÍ AÔÁ÷u 
CÆÁõµõ´a]°ß ÷{õUP©õS®. 
 
ö£¯º :      ÷uv :  
Á¯x :      EÒ ÷{õ¯õÎ Gs : 
£õÀ  :      Bµõ´a] ÷\ºUøP Gs : 
 
 C¢u Bµõ´a]°ß ÂÁµ[PÐ® Auß ÷{õUP[PÐ® ¬Êø©¯õP 
GÚUS ¬ÊÁx® öuÎÁõP ÂÍUP¨£mhx. 
 GÚUS ÂÍUP¨£mh Âå¯[PøÍ ¦¶¢xU öPõsk {õß Gß 
\®©uzøuz öu¶ÂUQ÷Óß. 
 GÚUS Cµzu¨ £¶÷\õuøÚ ö\´x öPõÒÍ \®©u®. 
 C¢u Bµõ´a]°À ¤Ó¶ß |º£¢uªßÔ Gß ö\õ¢u Â¸¨£zvß 
÷£¶À uõß £[S ö£ÖQ÷Óß ©ØÖ® {õß C¢u Bµõ´a]°¼¸¢x 
Gß÷{µ¬® ¤ß Áõ[P»õ® Gß£øu²® AuÚõÀ G¢u £õv¨¦® 
HØ£hõx Gß£øu²® ¦¶¢x öPõs÷hß. 
 {õß CµzuSÇõ´ Aøh¨¤ÚõÀ HØ£k® £UPÁõu® ÷{õ´ SÔzx 
C¢u Bµõ´a]°ß Â£µ[PøÍU öPõsh uPÁÀuõøÍ¨ ö£ØÖU 
öPõs÷hß. 
 Cuß -»® G¢u ¤ß ÂøÍÄ® Áµõx GÚ ©¸zxÁº -»® ¦¶¢x 
öPõsk GßÝøh¯ _¯ |øÚÄhß ©ØÖ® ¬Ê _u¢vµzxhß 
C¢u ©¸zxÁ Bµõ´a]°À GßøÚ ÷\ºzxU öPõÒÍ 
\®©vUQ÷Óß. 
 
Bµõ´a]¯õÍº øPö¯õ¨£®   £[÷PØ£õÍº øPö¯õ¨£® 
÷uv:  
ID 
no. 
Age Sex 
ECG Echocardiography 
NIHSS 
Risk factors 
 
arrhythmias 
ST-T 
changes 
EF % LVDD(Gr.) 
DM HTN CAD HF Alc HL CKD Thy 
old 
CVA 
adm 48h adm 48h adm 48h adm 48h 
1 56 m n n n n 60 55 0 0 8 y n n n n n n n n 
2 66 m n n n n 62 62 1 1 15 n y n n n n n n n 
3 74 m y y n n 60 58 0 0 14 y y n n n n n n y 
4 55 m n n y y 44 30 3 3 24 y y y y n n n n n 
5 55 f n n n n 60 60 0 0 8 n n n n n n n y n 
6 57 f n n n n 58 56 0 0 8 n y n n n n n n n 
7 60 f n n n n 44 42 0 0 16 y y n n n y n n n 
8 64 m n n n y 62 62 0 0 8 y n n n y n n n n 
9 80 m n y n n 54 54 1 1 12 n y n n n n n n y 
10 51 m n n n n 55 45 1 1 11 n n n n n n n n n 
11 69 f n n n n 36 30 1 3 28 y y n n n y n n n 
12 58 f n n n y 48 45 0 0 16 n y n n n n n n n 
13 70 m n n n n 60 60 2 2 12 y n n n n n n n n 
14 49 m n n n n 62 62 0 0 12 y n n n y n n n n 
15 64 f y y n n 46 40 0 0 24 y y y n n n n n y 
16 58 m n n n n 65 60 0 0 9 n n n n n n n n n 
17 44 m n n n n 58 55 0 0 14 n y n n n n n y n 
18 56 m n n n n 38 38 2 3 32 n y n n n n n n y 
19 77 f n n y y 44 38 0 0 16 y y n y n n n n n 
20 63 f n n n n 66 64 0 0 8 n n n n n y n n n 
21 54 f n n n n 52 52 0 0 16 n y n n n y n n n 
22 75 m n n n n 55 50 1 1 11 n n n n n n n n n 
23 66 m n n n n 62 62 0 0 8 n y y n n n n n n 
24 51 m n n n n 64 64 0 0 14 y n n n n n n n n 
25 79 f n n y y 56 55 1 1 24 y y n n n n n n y 
26 62 m n n n n 66 64 1 1 16 n n n n y y n n n 
27 55 f n n n n 46 46 2 2 14 n n n n n n n n n 
28 69 m n n n n 55 55 2 2 28 y y y n n n y n y 
29 49 f n n n n 62 62 0 0 8 n n n n n n n n n 
30 56 f n n n n 54 54 0 0 14 n n n n n n n n n 
31 81 m n n y y 45 30 2 2 20 y n n n n y y n y 
32 78 m n y n n 56 56 0 0 24 y y n n n n n n y 
33 74 f n n n n 64 60 0 0 16 n n y n n n n n n 
34 60 f n n n n 40 36 1 1 8 n y n n n n n n n 
35 70 m n n n y 64 64 0 0 14 n y n n n n n n n 
36 71 f y y n n 54 54 0 0 16 n y y n n n n n n 
37 45 f n n n n 58 56 0 0 12 n n n n n y n n n 
38 52 f n n n n 44 36 1 2 25 y y n n n n n n n 
39 49 m n n n n 60 56 1 1 8 n n n n y n n n n 
40 55 f n n n n 62 56 0 0 16 n y n n n n n n n 
41 60 m n n n y 36 36 2 2 32 n y n n n n n n y 
42 48 f n n n n 60 60 0 0 12 y n n n n n n n n 
43 46 m n n n n 64 58 1 1 16 n y n n n y n n n 
44 53 f n n n n 64 64 0 0 12 n n n n n n n n n 
45 57 f n n y y 54 54 1 1 26 y y n n n n y n n 
46 60 m n n n n 40 38 1 1 20 y n y y n n y n n 
47 63 m n y n n 56 55 0 0 18 n n n n n y n n y 
48 53 f n n n n 62 60 0 0 8 n n n n n n n n n 
49 77 f n n n n 56 56 0 0 12 n n n n n n n n n 
50 38 m n n n n 60 55 0 0 12 n y y n y n n n n 
51 42 m n n n n 64 62 0 0 8 n n n n y n n n n 
52 84 m n n y y 40 35 2 3 30 n y n n n n n n n 
53 79 f n n n n 64 62 0 0 10 n y n n n y n n n 
54 63 m y y n n 54 52 0 0 20 n y n n n n n n n 
55 65 f n n y y 48 48 1 1 7 n y n n n n n n n 
56 37 m n n n n 66 64 0 0 18 y n n n y y n n n 
57 45 m n n n n 54 54 0 0 12 n n n n y n n n y 
58 50 m n n n n 64 62 1 1 14 n y n n n n n n n 
59 53 f n n n n 60 60 0 0 10 n n n n n n n y n 
60 68 m n n y y 35 28 2 2 36 n y y y n n n n y 
61 62 f n n n n 46 44 1 1 24 n y n n n n n n n 
62 48 f n n n n 66 66 0 0 12 n n n n n y n n n 
63 53 m n n n n 56 54 0 0 28 n y n n y n n n n 
64 67 m n n n n 44 44 0 0 30 n y n n n n n y n 
65 73 f n n y y 56 56 1 1 28 y y n n n n n n y 
66 76 m n n n n 48 44 0 0 18 n y n n n n n n y 
67 59 m n n n n 45 40 0 1 8 n n n n n n n n n 
68 78 m n n y y 55 55 0 0 16 n n y n n n n n n 
69 66 f n y n n 50 44 0 0 24 n y n n n n n n n 
70 43 f n n n n 55 40 0 1 18 y n n n n n n n n 
71 37 m n n n n 66 66 0 0 12 n n n n y n n n n 
72 50 m n n n n 62 52 0 0 14 n y n n n y n n n 
73 66 f n n n n 30 30 2 2 22 n y y y n n n n n 
74 84 f y y n n 44 38 1 1 10 n n n y n n n n n 
75 75 f n n n n 54 54 0 0 22 y y n n n n n n y 
76 81 m n n y y 38 30 2 3 28 n y n n n n n n y 
77 65 f n n n n 56 52 0 0 12 n n n n n y n n n 
78 77 f n n n n 50 50 1 1 24 y y n n n n n n n 
79 70 m n n y y 34 30 3 3 30 n y n n n y n n n 
80 68 m y y n n 55 55 0 0 26 y y n n n n n n n 
81 58 f n n n n 60 60 0 0 8 n y n n n n n n n 
82 73 f n n n n 62 60 1 1 16 n n n n n y n n y 
83 84 m n n n n 42 36 1 2 26 y y n y n n y n n 
84 55 f n n n n 54 50 0 0 14 n y n n n n n n n 
85 70 f n n y y 60 54 2 2 27 n y n n n y n n n 
86 86 m n n n n 48 44 0 0 14 n n y n y n n n y 
87 43 m n n n n 65 65 0 0 8 y n n n y y n n n 
88 72 m n n n y 54 54 1 1 18 n n n n n n n n n 
89 64 f n n y y 40 34 2 3 22 n y n n n n n n n 
90 47 f n n n n 64 58 0 0 12 y n n n n y n n n 
91 59 m n y n n 54 54 1 2 20 n y n n n n n n n 
92 49 m n n n n 42 40 1 1 16 n y n n y n n n n 
93 75 m n n n n 38 36 3 3 34 y y n n n n n n y 
94 61 f y y n n 52 52 1 2 16 n y n n n n n n n 
95 67 m n n n n 42 28 2 2 30 y y n y n n n n n 
96 65 m n n n n 64 64 0 0 22 n y n n n n n n n 
97 84 f n n n n 50 46 2 3 8 n y n n n n n n n 
98 48 m n n n n 66 62 1 1 10 n n n n n y n n n 
99 57 f n n n n 46 44 0 0 16 y n n n n n n n n 
100 62 m n n n y 42 36 0 1 16 n n n y n n n n y 
 
KEY TO MASTER CHART 
m  - Male 
f  - Female 
 
y  - Yes / present 
n  - No / absent 
 
ECG - Electrocardiogram 
EF  - Ejectionfraction 
LVDD - Left Ventricular Diastolic Dysfunction 
NIHSS - National Institute of Health Stroke Scale 
CAD - Coronary artery disease 
CKD - Chronic kidney disease 
HL  - Hyperlipidemia 
HTN - Hypertension 
DM  - Diabetes mellitus 
HF  - Heart failure 
Alc  - Alcohol intake 
Thy  - Thyroid disorders 
CVA - Cerebrovascular accident 
  
 
 
 
